Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Cell Supply and Image Analysis

By Drug Discovery Trends Editor | January 1, 2008

Thermo Fisher Scientific CGDThermo Fisher Scientific introduced its Cell Growth and Discovery (CGD) WorkCell, an enclosed, environmentally-controlled automation solution for high capacity cell growth, supply, and in-line image analysis. Combining software with robotics, the CGD WorkCell can simultaneously handle multiple plate/flask formats and perform cell maintenance, colony selection, and RNAi studies.

It has been designed specifically for the growth and analysis of multiple cell lines and cultures. This high capacity system offers level II HEPA containment with strategic ports for user access while still protecting cells from contamination, and users from potentially hazardous aerosols and vapors. The CGD WorkCell can perform a wide variety of assays at the optimal point of cell growth and has extensive process flexibility to meet the culture and experimental demands of varying cell types. With the ability to accommodate multiple container formats, the CGD WorkCell can provide cells suitable for a variety of research needs, from cloning and transfection studies, to general cell line amplification in one system.

The WorkCell is powered by Celleste Software, which provides a user-friendly workflow management tool, can turn complex automated multi-cell line schedules into simple task buttons and configures process-specific operations for ease-of-use. Users can dynamically schedule automated cell growth, manipulation, and analytical procedures, tracking activities without actively managing complex cell growth programs. Additionally, the CGD WorkCell allows extensive method optimization and control monitoring. 24/7 operation enables long-term cell maintenance, providing alerts when cells are confluent and ready for use, and tracking reagents and consumable levels.

The Cell Growth and Discovery (CGD) WorkCell will be displayed at Booth 405 at Lab Automation 2008.

www.thermo.com/automate

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Roche in Drug Discovery & Development Pharma 50
Roche’s bispecific antibody Lunsumio wins priority review from FDA for non-Hodgkin lymphoma
Tiffany Hurd
CB Therapeutics biz dev lead sees upside for psychedelics in mental health and beyond
Pharmacovigilance
A new era of pharmacovigilance: Worldwide master key for drug safety monitoring
Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50